Biotechnology

WuXi Biologics Reports Outstanding Interim Results

* 52.4% Year-on-Year Revenue Growth to RMB1,607.1 Million * Net Profit Increased 80.1% Year-on-Year to RMB449.5 Million * Gross Profit Margin, Net Profit Margin and Adjusted Net Profit Margin All Record High * Total Backlog Surged to US$4.6 Billion * 32 New Integrated Projects Including 1...

2019-08-19 22:09 1348

WuXi AppTec Reports First Half 2019 Interim Results

* Revenue Accelerated 33.7% Year-Over-Year to RMB 5,894 Million * Gross Profit Up 30.0% Year-Over-Year to RMB 2,284 million[1] * Adjusted Non-IFRS Net Profit Attributable to Owners of the Company Up 32.0% Year-Over-Year toRMB 1,179 Million * Small Molecule CDMO/CMO Pipeline has Grown to 800...

2019-08-19 19:20 469

Abstract on CStone's CS1001-101 trial accepted for poster presentation at ESMO 2019 Annual Congress

SUZHOU, China, Aug. 19, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616) today announced that an abstract on the company's ongoing CS1001-101 Phase Ib clinical study has been accepted for poster presentation at the upcoming European Society for Medical Oncology (ESMO) 2019 Annua...

2019-08-19 13:50 1554

Conagen Expands Portfolio Beyond Gamma-Decalactone to 20 new non-GMO Lactones

Customers Choose from a Wider Spectrum of Flavor Profiles  BOSTON, Aug. 13, 2019 /PRNewswire/ -- Conagen, a Boston-based biotechnology company focusing on research and development, announced today its breakthrough development in the commercial production of natural aromatic compound, γ-Decalact...

2019-08-13 03:47 1450

Higher Levels of Automation Expand Revenue Potential for Analytical Instrumentation Manufacturers

Pharmaceuticals, biotechnology, and academics emerge major adopters of analytical equipment, finds Frost & Sullivan SANTA CLARA, California, Aug. 13, 2019 /PRNewswire/ -- The rise of the Industrial Internet of Things (IIoT) has given a significant boost to the global analytical instrumentation ma...

2019-08-13 00:19 1507

New Publication Shows Different Result of Risk Classification between GenesWell BCT and Oncotype DX in Breast Cancer Patients 50 Years Old or Younger.

SEOUL, South Korea, Aug. 12, 2019 /PRNewswire/ -- Gencurix, Inc., a company dedicated in development and market of innovative molecular diagnostics, announced the publication of a new study onFrontiers in Oncology comparing GenesWell™ BCT, a prognostic multigene test, with Genomic Health's Oncoty...

2019-08-12 21:00 1394

Samsung BioLogics Implements Large Scale N-1 Perfusion for Commercial Application

INCHEON, South Korea, Aug. 12, 2019 /PRNewswire/ -- Samsung BioLogics (SBL) has successfully performed N-1 (3,000L) perfusion with Alternating Tangential Flow (ATF) device to supply the 15,000L commercial production process in the Plant 3 facility at its manufacturing site in Songdo, S. Korea rec...

2019-08-12 19:00 929

The iQ Group Global named one of Australia's Top 5 Most Innovative Companies 2019

SYDNEY, Aug. 9, 2019 /PRNewswire/ -- The iQ Group Global  is honoured to be recognised as one of Australia andNew Zealand's Top 5 Most Innovative Companies by The Australian Financial Review and BOSS Magazine in its relentless pursuit to create the medicines of tom...

2019-08-09 18:46 1231

OssDsign AB (publ) Initiates Commercial Preparations for Launch in Japan Following Regulatory Filing for OssDsign Cranial

STOCKHOLM, Aug. 9, 2019 /PRNewswire/ -- OssDsign AB (publ) ("OssDsign" or the "Company"), the Swedish designer and manufacturer of innovative implants for bone regeneration, has filed for a Japanese regulatory approval of OssDsign Cranial. Subsequent to the filing, OssDsign initiates commercial p...

2019-08-09 14:57 1288

EnGeneIC Wins Innovation Award from Australian Financial Review

Named Most Innovative Healthcare Company of 2019 for its Nanocell Platform for Targeted Cyto-Immunotherapy in Cancer Treatment NEW YORK and SYDNEY, Aug. 9, 2019 /PRNewswire/ -- EnGeneIC Limited, a clinical-stage biopharmaceutical company advancing its proprietary EDV™ nanocell platform for targe...

2019-08-09 12:49 1196

DiscGenics Announces First Patients Treated in Japanese Clinical Trial of Cell Therapy for Degenerative Disc Disease

SALT LAKE CITY, Aug. 7, 2019 /PRNewswire/ -- DiscGenics, Inc., a clinical stage biotechnology company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, today announced the first patients have been ...

2019-08-07 21:00 1207

Corteva Agriscience Launches in Myanmar to Serve Farmers Better with the Newest Innovation in Seed and Crop Protection Technologies

YANGON, Myanmar, Aug. 7, 2019 /PRNewswire/ -- Pure-play global agriculture leader, Corteva Agriscience (NYSE:CTVA), has officially launched its brand in Myanmar. In conjunction with the brand launch, the company also introduced Zorvec® Encantia® fungicide - a new international award-winning diseas...

2019-08-07 10:30 6999

LUCA Biologics Launches to Develop Live Biotherapeutics for Women's Health Starting with Urinary Tract Infection (UTI)

CAMBRIDGE, Massachusetts, Aug. 6, 2019 /PRNewswire/ -- LUCA Biologics, a biotechnology company co-founded by Dr.Jacques Ravel, announced today it will develop live biotherapeutics for widespread, unmet medical needs in women's health. Ravel will serve as LUCA's Chief Scientist. The company's fir...

2019-08-06 18:00 1493

China Biologic Reports Financial Results for the Second Quarter of 2019

--2Q19 Total Sales Up 12.7% YoY in USD terms, or 20.4% YoY in RMB terms; Net Income Up 45.5% YoY to$41.6 Million; Non-GAAP Adjusted Net Income Up 29.1% YoY in RMB terms-- --1H19 Total Sales Up 14.0% YoY in USD terms, or 21.3% YoY in RMB terms; Net Income Up 31.7% YoY to$79.3 Million; Non-GAAP Ad...

2019-08-06 04:30 7354

Ascletis Received IND Approval and Management Outlook of 2019 and Beyond

HANGZHOU and SHAOXING, China, Aug. 5, 2019 /PRNewswire/ -- Ascletis Pharma Inc. (1672.HK), an innovative R&D driven, commercial-stage biotechnology company addressing unmet medical needs in therapeutic areas including anti-viral, cancer and fatty liver diseases, announces today that it received I...

2019-08-05 08:00 1511

Biosyngen Group Attends SLETC and Signs Contract of Dalian Sino-Singapore Biotech Hub

SINGAPORE, Aug. 2, 2019 /PRNewswire/ -- On July 29, 2019, at the invitation of Dalian Municipal People's Government, Mr.Frank Wang, Chairman of Biosyngen Group and Dr.Victor Li, CEO of Biosyngen Group attended the 10th Singapore-Liaoning Economic and Trade Council (SLETC) meeting inShenyang and ...

2019-08-02 10:24 668

ERBA Mannheim to Unveil NEXUS Next Generation Automation at AACC 2019

LONDON, Aug.1, 2019 /PRNewswire/ -- * New affordable, modular, mid-scale clinical chemistry, immunoassay and hematology range with sample selection and transport systems, making powerful automation accessible to growing labs * Hematology system uses unique combination of ultra-high defi...

2019-08-01 04:39 1356

Submission and acceptance of application for the production of new drug for Yisaipu(R)aqueous injection solution

SHANGHAI, July 29, 2019 /PRNewswire/ -- 3SBio Inc. (01530.HK), a leading biopharmaceutical company in the PRC, announces today that an application for the production of new drug has been submitted to the National Medical Products Administration for Yisaipu® pre-filled aqueous injection solution (...

2019-07-29 21:42 4030

Alvotech and Cipla Gulf Enter Into a Partnership for the Commercialization of Key Biosimilar in Select Emerging Markets

REYKJAVIK, Iceland and MUMBAI, India, July 29, 2019 /PRNewswire/ -- Biopharmaceutical company Alvotech and Cipla Gulf FZ LLC ("Cipla Gulf"), a wholly-owned subsidiary of the leading global pharmaceutical company Cipla Limited (BSE: 500087) (NSE: CIPLA EQ; hereafter referred to as "Cipla"), today ...

2019-07-29 12:00 4143

NeuroVive's NeuroSTAT Project Receives FDA Fast Track Designation

LUND, Sweden, July 28, 2019 /PRNewswire/ -- NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP) (OTCQX: NEVPF) today announced that the company's candidate drug NeuroSTAT, in development for treatment of moderate to severe traumatic brain injury, TBI, has received Fast Track designation from the ...

2019-07-28 21:47 4012
12345 ... 142